Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsuyoshi Muto

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|May 25, 2010
Direct laser writing of complementary logic gates and lateral p-n diodes in a solution-processible monolithic organic semiconductorJean Charles Ribierre, Takashi Fujihara, Satoshi Watanabe, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2017
Structure-based design, synthesis, and binding mode analysis of novel and potent chymase inhibitorsJunko Futamura-Takahashi, Taisaku Tanaka, Hajime Sugawara, et al.
Bioorganic & Medicinal Chemistry Letters|March 19, 2018
Structure-based drug design of 1,3,6-trisubstituted 1,4-diazepan-7-ones as selective human kallikrein 7 inhibitorsHidenobu Murafuji, Hiroki Sakai, Megumi Goto, et al.
Biochemical and Biophysical Research Communications|March 21, 2003
Mouse mast cell protease-1 cleaves angiotensin I to form angiotensin IIKayo Saito, Tsuyoshi Muto, Yoshiaki Tomimori, et al.
Bioorganic & Medicinal Chemistry|June 10, 2018
Structure-based drug design to overcome species differences in kallikrein 7 inhibition of 1,3,6-trisubstituted 1,4-diazepan-7-onesHidenobu Murafuji, Hajime Sugawara, Megumi Goto, et al.
European Journal of Pharmacology|October 25, 2003
Involvement of mast cell chymase in bleomycin-induced pulmonary fibrosis in miceYoshiaki Tomimori, Tsuyoshi Muto, Kayo Saito, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2007
Identification of 6-substituted 4-arylsulfonyl-1,4-diazepane-2,5-diones as a novel scaffold for human chymase inhibitorsTaisaku Tanaka, Tsuyoshi Muto, Hiroshi Maruoka, et al.
ACS Applied Materials & Interfaces|May 7, 2016
Microcrystallization of a Solution-Processable Organic Semiconductor in Capillaries for High-Performance Ambipolar Field-Effect TransistorsSatoshi Watanabe, Takuma Fujita, Jean-Charles Ribierre, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2015
2-Aminoalkyl nicotinamide derivatives as pure inverse agonists of the ghrelin receptorBitoku Takahashi, Hideaki Funami, Takehiko Iwaki, et al.
International Immunopharmacology|June 7, 2011
Pharmacokinetic/pharmacodynamic analyses of chymase inhibitor SUN13834 in NC/Nga mice and prediction of effective dosage for atopic dermatitis patientsAtsuto Ogata, Yusuke Fujieda, Maki Terakawa, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Advanced Materials (Deerfield Beach, Fla.)|May 25, 2010
Direct laser writing of complementary logic gates and lateral p-n diodes in a solution-processible monolithic organic semiconductorJean Charles Ribierre, Takashi Fujihara, Satoshi Watanabe, et al.
Bioorganic & Medicinal Chemistry Letters|December 2, 2017
Structure-based design, synthesis, and binding mode analysis of novel and potent chymase inhibitorsJunko Futamura-Takahashi, Taisaku Tanaka, Hajime Sugawara, et al.
Bioorganic & Medicinal Chemistry Letters|March 19, 2018
Structure-based drug design of 1,3,6-trisubstituted 1,4-diazepan-7-ones as selective human kallikrein 7 inhibitorsHidenobu Murafuji, Hiroki Sakai, Megumi Goto, et al.
Biochemical and Biophysical Research Communications|March 21, 2003
Mouse mast cell protease-1 cleaves angiotensin I to form angiotensin IIKayo Saito, Tsuyoshi Muto, Yoshiaki Tomimori, et al.
Bioorganic & Medicinal Chemistry|June 10, 2018
Structure-based drug design to overcome species differences in kallikrein 7 inhibition of 1,3,6-trisubstituted 1,4-diazepan-7-onesHidenobu Murafuji, Hajime Sugawara, Megumi Goto, et al.
European Journal of Pharmacology|October 25, 2003
Involvement of mast cell chymase in bleomycin-induced pulmonary fibrosis in miceYoshiaki Tomimori, Tsuyoshi Muto, Kayo Saito, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2007
Identification of 6-substituted 4-arylsulfonyl-1,4-diazepane-2,5-diones as a novel scaffold for human chymase inhibitorsTaisaku Tanaka, Tsuyoshi Muto, Hiroshi Maruoka, et al.
ACS Applied Materials & Interfaces|May 7, 2016
Microcrystallization of a Solution-Processable Organic Semiconductor in Capillaries for High-Performance Ambipolar Field-Effect TransistorsSatoshi Watanabe, Takuma Fujita, Jean-Charles Ribierre, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2015
2-Aminoalkyl nicotinamide derivatives as pure inverse agonists of the ghrelin receptorBitoku Takahashi, Hideaki Funami, Takehiko Iwaki, et al.
International Immunopharmacology|June 7, 2011
Pharmacokinetic/pharmacodynamic analyses of chymase inhibitor SUN13834 in NC/Nga mice and prediction of effective dosage for atopic dermatitis patientsAtsuto Ogata, Yusuke Fujieda, Maki Terakawa, et al.
Pageof 4